How Much Did Biorep Technologies Raise?
Funding & Key Investors

Biorep Technologies has solidified its market position through a series of strategic capital injections, culminating in a total valuation trajectory represented by $630K. The firm recently secured a major strategic investment of $280K, underscoring its critical role in the medical device manufacturing ecosystem. This infusion of liquidity serves to bolster the company's long-standing commitment to high-precision engineering and regulatory excellence within the life sciences sector.

What is Biorep Technologies?

Biorep Technologies
ManufacturingMedical Devices & EquipmentBusiness Services

Founded in 1994, Biorep Technologies operates as a specialized development firm with a singular focus on the medical device industry. With over two decades of operational history, the company maintains ISO 13485 certification and FDA registration, positioning it as a trusted partner for complex research initiatives, including its foundational work with the Diabetes Research Institute. By bridging the gap between conceptual biological research and scalable medical product development, Biorep provides the technical infrastructure necessary for clinical breakthroughs. The company's expertise spans the entire product lifecycle, from initial design and prototyping to rigorous regulatory compliance and manufacturing, ensuring that innovative medical solutions reach the clinical environment with precision and reliability.

How much funding has Biorep Technologies raised?

Biorep Technologies has raised a total of $630K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$280K

Debt (2020): $350K with participation from PPP

Debt (2021): $280K led by PPP

Key Investors in Biorep Technologies

PPP

Public-Private Partnership

What's next for Biorep Technologies?

With the recent influx of capital, Biorep Technologies is well-positioned to scale its manufacturing capabilities and deepen its R&D pipeline. The strategic allocation of these funds will likely prioritize the expansion of its ISO-certified facilities and the integration of advanced manufacturing technologies to meet the growing demand for specialized medical hardware. As the company continues to support the Diabetes Research Institute and other research partners, this financial backing provides the necessary runway to accelerate the development of next-generation therapeutic devices. Moving forward, Biorep is expected to leverage its established regulatory framework to navigate the increasingly complex landscape of medical device approval, further cementing its status as a cornerstone of the biomedical engineering community.

See full Biorep Technologies company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturing
Building MaterialsManufacturing
Food & BeverageManufacturing
FurnitureManufacturing

Frequently Asked Questions Regarding Biorep Technologies Financial Insights

What are the most recent funding rounds that Biorep Technologies has completed, and what were the funding rounds?
Biorep Technologies has recently completed 2 funding rounds: Debt on Feb 11, 2021, Debt on Apr 11, 2020.
What is the total amount of funding Biorep Technologies has raised to date?
Biorep Technologies has raised a total of $630K in funding to date.
How many funding rounds has Biorep Technologies completed?
Biorep Technologies has completed 2 funding rounds.
How much funding did Biorep Technologies raise in its most recent funding round?
Biorep Technologies raised $280K in its most recent funding round.
Who are the lead investors in Biorep Technologies's latest funding round?
The lead investor in Biorep Technologies's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Biorep Technologies's history?
The largest funding round in Biorep Technologies's history was $350K.
See more information about Biorep Technologies